15-84935179-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BA1
The NM_004213.5(SLC28A1):āc.1368A>Gā(p.Gln456Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.88 in 1,613,972 control chromosomes in the GnomAD database, including 626,315 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: š 0.89 ( 61089 hom., cov: 31)
Exomes š: 0.88 ( 565226 hom. )
Consequence
SLC28A1
NM_004213.5 synonymous
NM_004213.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.228
Genes affected
SLC28A1 (HGNC:11001): (solute carrier family 28 member 1) Enables azole transmembrane transporter activity; cytidine transmembrane transporter activity; and uridine transmembrane transporter activity. Involved in azole transmembrane transport; nucleoside transport; and pyrimidine-containing compound transmembrane transport. Located in cytosol; nuclear speck; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 15-84935179-A-G is Benign according to our data. Variant chr15-84935179-A-G is described in ClinVar as [Benign]. Clinvar id is 3060136.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-0.228 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.941 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC28A1 | NM_004213.5 | c.1368A>G | p.Gln456Gln | synonymous_variant | 14/19 | ENST00000394573.6 | NP_004204.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC28A1 | ENST00000394573.6 | c.1368A>G | p.Gln456Gln | synonymous_variant | 14/19 | 1 | NM_004213.5 | ENSP00000378074.1 | ||
SLC28A1 | ENST00000286749.3 | c.1368A>G | p.Gln456Gln | synonymous_variant | 13/18 | 1 | ENSP00000286749.3 | |||
SLC28A1 | ENST00000538177.5 | c.1084-8266A>G | intron_variant | 2 | ENSP00000443752.1 |
Frequencies
GnomAD3 genomes AF: 0.895 AC: 136043AN: 152056Hom.: 61029 Cov.: 31
GnomAD3 genomes
AF:
AC:
136043
AN:
152056
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.885 AC: 222499AN: 251446Hom.: 98702 AF XY: 0.885 AC XY: 120248AN XY: 135898
GnomAD3 exomes
AF:
AC:
222499
AN:
251446
Hom.:
AF XY:
AC XY:
120248
AN XY:
135898
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.879 AC: 1284588AN: 1461798Hom.: 565226 Cov.: 55 AF XY: 0.880 AC XY: 639758AN XY: 727212
GnomAD4 exome
AF:
AC:
1284588
AN:
1461798
Hom.:
Cov.:
55
AF XY:
AC XY:
639758
AN XY:
727212
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.895 AC: 136164AN: 152174Hom.: 61089 Cov.: 31 AF XY: 0.895 AC XY: 66567AN XY: 74372
GnomAD4 genome
AF:
AC:
136164
AN:
152174
Hom.:
Cov.:
31
AF XY:
AC XY:
66567
AN XY:
74372
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3248
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
SLC28A1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 30, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at